Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,226 reports matching your criteria)
  • Biopharmaceutical Fermentation Systems

    ... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More

  • Brain Computer Interface

    ... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More

  • Extracorporeal CO2 Removal Devices

    ... reach US$151.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and ... Read More

  • Desmopressin

    ... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More

  • Venturi Masks

    ... at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of ... Read More

  • Vancomycin

    ... of 4.9% over the analysis period 2023-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis ... Read More

  • Insulin Pens

    ... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More

  • Oncology Based In-Vivo CRO

    ... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More

  • Pesticide Inert Ingredients

    ... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.3 Billion by the ... Read More

  • Microwave Ablation

    ... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More

  • Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

    ... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More

  • Orphan Drugs

    ... at a CAGR of 11.9% over the analysis period 2023-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$286.3 Billion by the end of ... Read More

  • Diabetic Shoes

    ... at a CAGR of 8.1% over the analysis period 2023-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end ... Read More

  • Natural Antioxidants

    ... at a CAGR of 5.9% over the analysis period 2023-2030. Vitamin C, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of ... Read More

  • Acne Drugs

    ... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More

  • Soft Tissue Repair

    ... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Fixation Products, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.6 Billion by ... Read More

  • Travel Vaccines Market: Global Market Size, Forecast, Insights, and Competitive Landscape

    ... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global travel vaccines market by segmenting the market based on ... Read More

  • Sodium Alginate

    ... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More

  • Nail Care

    ... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More

  • Restorative Dentistry

    ... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More

  • Veterinary Pain Management

    ... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More

  • LED Video Walls

    ... by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by ... Read More

  • Patient Monitoring Devices

    ... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More

  • Probiotics Dietary Supplements

    ... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by ... Read More

  • Cervical Dysplasia Diagnostics

    ... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by ... Read More

Cookie Settings